logoadit_white.png
Save the dates 

April 24 - 26, 2023

" With the support and contribution of top researchers and experts in medical science, we strive to translate research into clinical practice. "

Dear colleagues.

It is a privilege and pleasure to invite you to participate in the 11th ADIT conference from April 24 - 26, 2023.

Medical innovation and research have provided new approaches for preventing, diagnosing, and managing diabetes regardless of two years of COVID pandemic-induced hiatus in live CME events. 

To implement such innovation into effective practice, we prepared a clinical oriented, evidence based ADIT 2023 program.

In a cycle of 10 conferences, ADIT has evolved into one of the most influential CME meetings in SEE, with a 99 % impact of the presented knowledge on clinical practice (based on the ADIT 2018 survey). Therefore, the ADIT conferences contributed substantially to implementing the latest research and innovations in patient care and clinical outcomes.

With the support and contribution of top researchers and experts in medical science, we strive to translate research into clinical practice and enable a broad audience of physicians to access such knowledge through the ADIT program. 

The program adheres to the principles of unbiased independent medical education in the best interest of patients and the medical profession. Tailored to the educational needs of participants, it provides physicians with powerful tools and methods for managing diabetes.

Ass.Prof. Dario Rahelic

ADIT Chairman

Tracks_bebasFont.png

Interdisciplinary treatment & complications: Diabetes and ....

  • Heart (CVD)

  • Liver (NAFLD)

  • Kidney (CKD)

  • Neuropathy 

  • Mental health 

Lifestyle Modifications:

  • Diabesity & Weight management

  • Nutrition

  • Exercise

Good to know:

  • Patient centred approach 

  • Moving target : HBA1C goals from childhood to old age

  • Hypo and hiper glycemia (causes & prevention)

  • TIR and A1C correlation

Pharmacological treatment and therapies:

  • Latest on: developments, agents and therapies

  • Updates: Insulins, DPP4, SGLT2, SU, GLP1, Metformin ...

  • Efficacy and Safety 

 
ADIT Organiser
ADIT Secretariat

info@adit-conf.org

Robova cesta 6, 1360 Vrhnika

Slovenia - Europe

Stay in touch & subscribe

Thanks for submitting!